Project #561

Sodium Arsenite Studies in p53 +/- Mice

$242,259
Completed
Principal Investigator
Raymond
Tice
Research Manager
Jarmila Popovicova
Contractor
Integrated Laboratory Systems, Inc.
Constituents of Emerging Concern (CECs)
Risk Assessment

Abstract

Evaluates the carcinogenicity of sodium arsenite as a function of hepatic methyl donor status. Also investigates the ability of sodium arsenite to promote bladder carcinogenicity and skin carcinogenicity as a function of hepatic methyl donor availability. Reports findings from investigations using heterozygous p53 deficient male mice receiving chronic administrations of arsenic in drinking water. Research partner: USEPA and ACWA. Published in 2000.

Resources